Regadenoson and Adenosine
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.
Also called NCT01809743
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Lokien van Nunen
- Registry
-
NCT01809743
-
- Other papers using this trial's data
- Single bolus intravenous regadenoson injection versus central venous infusion of adenosine for maximum coronary hyperaemia in fractional flow reserve measurement
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT01809743. Randomized; no masking; primary purpose diagnostic. Start 2013-01 (registry gives no type); primary completion 2013-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Regadenoson and Adenosine
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Regadenoson central -central
- Intervention (Drug)
- Regadenoson peripheral - peripheral
- Intervention (Drug)
- Regadenoson central - peripheral
- Intervention (Drug)
- Regadenoson peripheral - central
- Intervention (Drug)
- Adenosine
- Lead sponsor
- Lokien van Nunen
Record details
- Record id
cardio:ct-nct01809743- Content hash
ddfe46d6c6835c3b6c03b049c9c8e1266886d3965548873f7864bdab37f65ea9